CD8+蕈样肉芽肿:一种低度恶性淋巴增殖性疾病
结果显示CD8+ MF诊断时早期比例更高(IA期47%、IB期50%),完全缓解率65.5%更高、进展率更低,提示病程更惰性,支持以皮肤定向治疗和观察为主的保守策略。
要点
- CD8+ MF诊断时多为早期(IA期47%、IB期50%),IIB期仅3%。
- 完全缓解率65.5%,进展率低于CD4+为主队列。
- 多数患者可采用皮肤定向治疗和观察的保守策略。
核心结论
- CD8+ MF病程较CD4+ MF更惰性,完全缓解率更高、进展率更低。
- 结果支持对多数CD8+ MF患者采用皮肤定向治疗和观察的保守策略。
研究设计与样本
- 将本中心患者的年龄、初诊分期和结局与文献中两个以CD4+为主的大MF队列比较。
主要发现
- 诊断时早期比例高于其他队列:IA期31例(47%)、IB期33例(50%)、IIB期2例(3%),对应P值分别为.001、.001和.002。
- 中位随访5.5年(范围0.2-21年),完全缓解率65.5%(P=.001),进展率更低(P=.004)。
临床怎么用
- 对CD8+ MF患者可考虑以皮肤定向治疗和观察为主的保守处理。
局限性
- 本研究为回顾性综述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognosis of the CD8+ subtype of mycosis fungoides (MF) is controversial. Although most authors believe that determining the presence of this cell surface antigen has no prognostic value, others have observed a more indolent course for CD8+ MF compared with CD4+ MF. OBJECTIVES: To review the cases of CD8+ MF in the pediatric and adult populations seen at our institution. METHODS: This is a retrospective review of clinical and pathologic data. Age, stage at presentation, and outcomes of patients at our institution were compared with those of 2 large MF cohorts that predominantly were CD4+ from the relevant literature. RESULTS: Sixty-seven patients of a median age of 46 years were included. A higher frequency of early-stage disease was observed for CD8+ MF patients at diagnosis when compared with other cohorts, including 31 (47%) patients with stage IA, 33 (50%) with stage IB, and 2 (3%) with stage IIB (P = .001, P = .001, and P = .002, respectively). With a median follow-up (5.5 years, range 0.2-21 years) similar to other cohorts, a higher rate of complete remission was achieved (65.5%, P = .001), and a lower rate of progression was observed (P = .004). LIMITATIONS: This is a retrospective review. CONCLUSION: Our experience with CD8+ MF confirms a more indolent course of disease with this MF variant. Our results warrant a conservative treatment approach limited to skin-directed therapies and observation in most patients.
引用
- Martinez-Escala ME, Kantor RW, Cices A, et al. CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. J Am Acad Dermatol. 2017. PMID: 28676328. doi:10.1016/j.jaad.2017.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。